Brind.

Ardelyx announced new data for IBSRELA, referencing Trump-era tariffs and onshoring trends.

1 report, 1 independent Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ardelyx announced new data for IBSRELA, referencing Trump-era tariffs and onshoring trends.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Linzess and Ibsrela are drugs in the IBS-C space, and Ibsrela targets viewers via streamers like Netflix.Sub-event
  2. Ardelyx released new data related to IBSRELA amidst discussions of Trump-era tariffs.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyArdelyx (ARDX) Announced New data for IBSRELA Ardelyx, Inc. (NASDAQ:ARDX) is one of the Best American Penny Stocks to Buy According to Analysts. On May 6, Ardelyx, Inc. (NASDAQ:ARDX) announced new da